择期胃肠癌手术围术期红细胞输注的医师与医院差异
基于加拿大安大略省2007至2019年行政健康数据,纳入59,964例择期胃肠癌切除术患者,18.0%接受围术期红细胞输注。病例组合解释12.8%的变异,医师间和医院间系统差异分别解释2.8%和2.1%,对应相似患者输注 odds 约30%差异。
要点
- 择期胃肠癌手术患者中18.0%接受围术期红细胞输注。
- 患者因素解释12.8%的输注变异,医师和医院分别解释2.8%和2.1%。
- 相似患者由不同医师或医院治疗,输注 odds 约差30%。
核心结论
- 输血提供主要由患者因素驱动,但治疗医师和医院对变异的影响重要,反映可通过针对可修改的诊疗流程来标准化围术期红细胞输注实践的机会。
研究设计与样本
- 使用加拿大安大略省关联行政健康数据集,识别2007至2019年间接受择期胃肠癌切除术的患者。
- 采用漏斗图描述经病例组合调整后的输血使用变异,并用分层回归模型量化患者层面、医师间和医院间变异。
主要发现
- 共纳入59,964例患者(中位年龄69岁;43.2%女性;75.8%结直肠切除),18.0%接受围术期红细胞输注。
- 患者特征(如年龄、合并症和手术类型)合计解释12.8%的变异。
- 调整病例组合后,医师间和医院间系统差异分别解释2.8%和2.1%的变异。
- 相似两名患者由不同医师治疗,输注 odds 中位比值比为1.35(95%CI 1.30-1.40);由不同医院治疗,中位比值比为1.30(95%CI 1.23-1.42)。
- 在各手术类型亚组中观察到可比效应。
临床怎么用
- 临床应关注医师和医院层面的可修改诊疗流程,以减少围术期红细胞输注实践的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients undergoing gastrointestinal cancer surgery often receive packed red blood cell transfusions. Understanding practice variation is critical to support efforts working toward responsible transfusion use. We measured the extent and importance of variation in perioperative packed red blood cell transfusion use across physicians and hospitals among gastrointestinal cancer surgery patients. METHODS: We identified patients who underwent elective gastrointestinal cancer resection between 2007 and 2019 using linked administrative health data sets in Ontario, Canada. We used funnel plots to describe variation in transfusion use, adjusted for patient case mix. Hierarchical regression models quantified patient-level, between-physician, and between-hospital variation in transfusion use with R2 measures, variance partition coefficients, and median odds ratios. RESULTS: Of 59,964 included patients (median age 69 years; 43.2% female; 75.8% colorectal resections), 18.0% received perioperative packed red blood cell transfusions. Funnel plots showed variation in transfusion use among physicians and hospitals. Patient characteristics, such as age, comorbidity, and procedure type, combined to explain 12.8% of the variation. After adjusting for case mix, systematic between-physician and between-hospital differences were responsible for 2.8% and 2.1% of the variation, respectively. This translated to an approximately 30% difference in the odds of transfusion for 2 similar patients treated by distinct physicians (median odds ratio: 1.35, 95% confidence interval 1.30-1.40) and hospitals (median odds ratio: 1.30, 95% confidence interval 1.23-1.42). We observed comparable effects across procedure-type subgroups. CONCLUSION: Transfusion provision is highly driven by patient factors. Yet the impact of the treating physician and hospital on variation relative to other factors is important and reflects opportunities to target modifiable processes of care to standardize perioperative packed red blood cell transfusion practice.
引用
- Zuckerman J, Coburn N, Callum J, et al. Evaluating variation in perioperative red blood cell transfusion for patients undergoing elective gastrointestinal cancer surgery. Surgery. 2022. PMID: 36336508. doi:10.1016/j.surg.2022.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。